Anesthesia Gases Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Anesthesia Gases Market is Segmented by Product Type (Anesthesia Gases and Vaporizer Devices), End User (Hospitals, Ambulatory Surgery Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Global Anesthesia Gases Market Size

Single User License
Team License
Corporate License
Book before:
Anesthesia Gases Market Summary
share button
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 4.00 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Anesthesia Gases Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Global Anesthesia Gases Market Analysis

The anesthesia gas market is expected to witness a CAGR of 4% during the forecast period.

The emergence of the COVID-19 pandemic had a significant effect on the world economy and the healthcare system. Due to the rising number of cases of COVID-19 in the early stages of the pandemic, all hospitals around the world canceled all elective procedures. For instance, according to an article published by Lancet Rheumatology in February 2021, a study was conducted in the United Kingdom, which showed that during the COVID-19 pandemic, many elective surgeries were postponed, and there was a long waiting time for elective surgeries. The cancellation of many surgical procedures had a negative impact on the studied market. However, as the pandemic has subsided currently, the studied market is expected to have stable growth during the forecast period of the study.

In addition, the increasing geriatric population prone to chronic diseases and the rising number of emergency cases are actively affecting the growth of the studied market. For instance, according to the British Heart Foundation Factsheet, published in August 2022, about 7.6 million people were living with heart or circulatory diseases in the United Kingdom. Also, as per the same source, it is estimated that in the United Kingdom, more than half of the people will get a heart or circulatory condition in their lifetime, and around twice as many people are living with heart and circulatory diseases in the United Kingdom than with cancer and Alzheimer's disease combined. It is also estimated that around 48,000 people under the age of 75 in the United Kingdom die from heart and circulatory diseases each year.

Moreover, a steep rise in the incidences of sports-related and spinal cord injury (SCI) and accidental fracture cases resulted in surgical procedures, thus leading to more usage of anesthesia gases. For instance, according to the National Spinal Cord Injury Statistical Center report in 2022, the annual incidence of traumatic spinal cord injury (SCI) last year was approximately 54 cases per one million people in the United States, which equals about 18,000 new SCI cases each year. The estimated number of people with SCI living in the United States last year was approximately 299,000 persons, with a range from 253,000 to 378,000 persons. Thus, the increasing prevalence of spinal cord injury is expected to increase the demand for surgical procedures, thereby boosting the usage of anesthesia gases.

Furthermore, the increasing product launches by key market players are also enhancing market growth. For instance, in February 2022, Sedana Medical AB launched Sedaconda (isoflurane) in Germany. Sedaconda received European DCP approval in July 2021.

Therefore, owing to the aforementioned factors, such as the rising prevalence of chronic diseases, rising surgical procedures, and product launches by key market players, the studied market is anticipated to witness growth over the analysis period. However, increasing generic anesthesia usage and side effects of anesthesia gases are likely to impede market growth.

Global Anesthesia Gases Market Trends

Isoflurane Gas is Expected to Witness Significant Growth Over The Forecast Period

Isoflurane is commonly used for induction and maintenance of general anesthesia in the operating room. The increasing number of emergency departments and surgical interventions and the rising geriatric population prone to chronic diseases are expected to drive the segment growth.

According to an article updated by NCBI in August 2022, isoflurane is a volatile anesthetic gas approved by the FDA for the induction and maintenance of general anesthesia, and unlike other common anesthesia gases, isoflurane is a non-flammable volatile anesthetic gas. The source also stated that with regards to cardiac function, isoflurane has minimal impact on left ventricular function, but it does cause a dose-dependent decrease in systemic vascular resistance due to mild beta-adrenergic stimulation. Thus, the increasing advantages of isoflurane are expected to boost segment growth.

Companies offering products are innovating and launching new products and engaging in business expansion initiatives such as mergers and acquisitions, collaborations, and partnerships. For instance, in January 2022, the company Dechra Pharmaceuticals acquired Isoflurane USP from Halocarbon Life Sciences. This indicates the demand for isoflurane among pharmaceutical companies. These activities are further expected to augment the growth of the isoflurane segment during the forecast period of study.

Thus, the adoption of isoflurane gas is expected to increase during the forecast period of study due to the above-mentioned factors, such as the increasing number of emergency department cases and surgical interventions and the rising geriatric population prone to chronic diseases.

Anesthesia Gases Market: Population aged 65 years or over (in % percentage), Global, 2022-2050

North America is Expected to Hold a Significant Share in the Anesthesia Gases Market Over The Forecast Period

North America is expected to hold a significant share of the overall market, throughout the forecast period. This is due to the rising geriatric population and increased surgical procedures in the region.

According to the National Spinal Cord Injury Statistical Center in 2022, about 30% of persons with spinal cord injury (SCI) are re-hospitalized one or more times during any given year following injury, and among those re-hospitalized, the length of hospital stay averages about 18 days in the United States. Hence, due to the rising number of spinal cord injuries in the United States, spinal cord surgeries are also expected to increase, leading to more usage of anesthesia gases.

Moreover, the rising incidence of spinal cord injury in Canada is also expected to enhance the market growth in the region. For instance, according to an article published by frontiers in November 2022, it is estimated that in Canada more than 86,000 people are affected by spinal cord injuries every year, from either a traumatic (e.g., fall) or non-traumatic injury (e.g., tumor).

Therefore, owing to the above-mentioned factors such as the rising geriatric population and increased surgical procedures, the growth of the studied market is anticipated in the North America Region.

Anesthesia Gases Market : Growth rate by Region

Global Anesthesia Gases Industry Overview

The anesthesia gas market is fragmented due to the presence of many companies. The competitive landscape includes an analysis of a few international and local companies that hold significant market shares and are well known. Some of the companies in the market are AbbVie Inc., Baxter, Drägerwerk AG & Co. KGaA, Fresenius SE & Co. KGaA, GE Healthcare, Mindray Medical International Limited, and Piramal Enterprise Ltd.

Global Anesthesia Gases Market Leaders

  1. AbbVie Inc.

  2. Baxter

  3. Fresenius SE & Co. KGaA

  4. Drägerwerk AG & Co. KGaA

  5. GE Healthcare

*Disclaimer: Major Players sorted in no particular order

Anesthesia Gases Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Global Anesthesia Gases Market News

  • Sept 2022: The Government of Zimbabwe (GoZ) launched its first National Surgical, Obstetric, and Anesthesia Strategy (NSOAS) 2022-2025. This strategy will promote access to surgical services from the district level, and it will play a central role in surgery and anesthesia care in the country.
  • Jun 2022: Kootenay Lake Hospital of Canada announced that to reduce its greenhouse gas footprint, the hospital made substantial changes to the hospital's anesthetic gas usage. It is using sevoflurane in 99% of the hospital procedures requiring anesthesia, as sevoflurane is considered 13 times less harmful as a greenhouse gas than desflurane.

Anesthesia Gases Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Geriatric Population Prone To Chronic Diseases

      2. 4.2.2 Increasing Number of Emergency Cases

    3. 4.3 Market Restraints

      1. 4.3.1 Increasing Generic Anesthesia Usage

      2. 4.3.2 Side Effects of Anesthesia Gases

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product Type

      1. 5.1.1 Anesthesia Gases

        1. 5.1.1.1 Desflurane

        2. 5.1.1.2 Sevoflurane

        3. 5.1.1.3 Isoflurane

        4. 5.1.1.4 Nitrous Oxide

        5. 5.1.1.5 Other Anesthesia Gases

      2. 5.1.2 Vaporizer Devices

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Ambulatory Surgery Centers

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc.

      2. 6.1.2 Baxter International Inc.

      3. 6.1.3 Dragerwerk AG & Co. KGaA

      4. 6.1.4 Fresenius SE & Co. KGaA

      5. 6.1.5 GE Healthcare

      6. 6.1.6 Mindray Medical International Limited

      7. 6.1.7 BPL Group (Penlon)

      8. 6.1.8 MSS International Ltd

      9. 6.1.9 OES Medical

      10. 6.1.10 Piramal Enterprise Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Anesthesia Gases Industry Segmentation

As per the scope of the report, anesthesia gases are used for the induction and maintenance of general anesthesia and sedation. The most common gases are sevoflurane, desflurane, and nitrous oxide. 

The Anesthesia Gases Market is Segmented by Product Type (Anesthesia Gases and Vaporizer Devices), End User (Hospitals, Ambulatory Surgery Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product Type
Anesthesia Gases
Desflurane
Sevoflurane
Isoflurane
Nitrous Oxide
Other Anesthesia Gases
Vaporizer Devices
By End User
Hospitals
Ambulatory Surgery Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Anesthesia Gases Market Research FAQs

The Global Anesthesia Gases Market is projected to register a CAGR of 4% during the forecast period (2024-2029)

AbbVie Inc., Baxter, Fresenius SE & Co. KGaA, Drägerwerk AG & Co. KGaA and GE Healthcare are the major companies operating in the Global Anesthesia Gases Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Global Anesthesia Gases Market.

The report covers the Global Anesthesia Gases Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Anesthesia Gases Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Global Anesthesia Gases Industry Report

Statistics for the 2024 Global Anesthesia Gases market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Anesthesia Gases analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Anesthesia Gases Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)